-
Presenters: Tom O’Bryan, DC, CCN, DACBN
-
Webinar Date: February 9, 2023
-
Format: 1 hr webinar recording
-
Registration: FREE
The sweetness of a canary’s song brings a sense of calm and serenity. Yet, that same sweet sound, or lack thereof, can be a harbinger of grave danger. The brain has been referred to as the ‘Canary in the Coal Mine’ of chronic inflammatory diseases.
Every scientist agrees that inflammation is the fuel on the fire of brain deterioration. Are we truly reducing the entire inflammatory cascade in the brain with our protocols (whether it’s GABA, or Valerian, or chamomile, or rhodiola, or Omega 3’s, or…)? Symptom relief, as wonderful as it is, does not always correlate with eliminating ongoing brain inflammation and degeneration. How do you know what to do?
Accurate laboratory identification of a breach of the Blood Brain Barrier (BBB), and biomarkers of a brain on fire are essential in understanding the scope of brain inflammation. As brain inflammation biomarkers reduce, and symptoms diminish, the clinician can monitor and adjust protocols.
Initial brain inflammation, with improvements clearly documented on follow up tests keeps the patient engaged, empowered, and reinforces they are on the right path to reverse the direction of brain deterioration that eventually manifests as dementia.
In this presentation, Dr. Tom O’Bryan will address both the latest cutting-edge laboratory testing to identify the mechanisms of BBB permeability, the most common triggers of a ‘Brain on Fire’, and the over 40 biomarkers (gauges on the dashboard) of a brain on fire.
Stay in the know.
Sign-up now for updates, news and exclusive offers! Let’s redefine mental wellness together.
By submitting your information, you agree to receive future email communications from us. We promise to keep your information private, and you can easily unsubscribe at any time.
